Neonatal Eye Defects and Stem Cell Therapeutics
Journal Title: International Journal of Stem Cell Research and Transplantation (IJST) - Year 2016, Vol 4, Issue 6
Abstract
Present review aims to describe various neonatal eye defects and its stem cell therapeutics. This article attempts to highlight common causes of visual impairment in infants and present the recent approaches used for restoration of normal vision in patients. The article highlights the need for setting microenvironment or stem cell micro niche for regeneration of opticneural complexes. Till date no proven drug based treatment existed for inherited eye defects. By adopting different therapeutic measures causal effects can be improved. The article advocates cell based therapeutics for wound healing of optical tissues for functional restoration using appropriate and suitable cell transplantations in animal models. In addition, possible solutions have been suggested to reduce the pain in newborns and infants from serious life-threatening visual complications or infection induced visual pathogenesis. This article emphasizes use of stem cell derived lens cells for human lens development and regeneration of corneal and retinal cells for increasing future therapeutic applications. As an alternative remedy exploring and designing new biomaterials to make matrix based nano-structure constructs for corneal repair and regeneration has been suggested. Bioengineered corneal devices are addressed with safe use of tissue-engineered hydrogels to allow regeneration of radiosensitivity in neural-visual cell complex. Present review presents new advancements in the field of biocompatible substrates, bio-matrix, transplantation methods and micro-niche maintaining factors for restoration, repairing and healing of visual-neuroepithelial complexes successfully.
Authors and Affiliations
Ravi Kant Upadhyay
Keywords
Related Articles
- EP ID EP198042
- DOI 10.19070/2328-3548-1600032
- Views 81
- Downloads 0
Re-Engraftment of Prior Cord Blood Graft in a Patient with Relapsed/Refractory Acute Myeloid Leukaemia following Haploidentical Transplantation
We report the case of a 32-year-old man with poor risk acute myeloid leukemia (AML) who received transplantation of an UCB graft following myeloablative conditioning but unfortunately relapsed after one year with complet...
Angiogenesis Induction using Dental Pulp Stem Cells, A Collagen Scaffold Seeded in Pulp Chamber of Endodontically Treated Teeth and Subcutaneously Transplanted into Immunocompromised Mice
Background: Angiogenesis is an essential mechanism for repairing any damaged target tissues or organs in cell therapy because the process can provide the supplements of nutrients, oxygen, and other repair factors. Many s...
Evolution of Immunosuppressive Agents in Renal Transplantation: An Updated Review
Suppression of allograft rejection is the central issue in renal transplantation (RT). Thus, development of immunosuppressive agents is the key for successful allograft function. Immunosuppression agents in RT have evolv...
Intravitreal Bevacizumab Followed by Ranibizumab for Neovascular Age Related Macular Degeneratıon
Purpose: To compare the outcomes after switching from intravitreal bevacizumab (IVB) to intravitreal ranibizumab (IVR) in patients with neovascular age related macular degeneration (ARMD). Material and Methods: A retrosp...
Human Umbilical Cord Matrix - Derived Stem Cells Show Tropism Towards the Human Glioma Microenvironment
Objective: Glioblastoma multiforme (GBM) is an aggressive type of brain tumor in humans. The median survival of patients is a year after diagnosis. It is a great challenge to identify new therapeutic strategies that coul...